- Primary objective: evaluate and compare safety of the [[FDC]] against [[albendazole]] alone via [[MDA]] in two study areas in [[Kenya]] and [[Ghana]]
- Primary objective: evaluate and compare safety of the [[FDC]] against [[albendazole]] alone via [[MDA]] in two study areas in [[Kenya]] and [[Ghana]]
- Secondary objectives:
- Secondary objectives:
- Evaluate the effectiveness of one round of [[MDA]] with [[FDC]] vs [[albendazole]] against [[STH]] by microscopy
- Evaluate the effectiveness of one round of [[MDA]] with [[FDC]] vs [[albendazole]] against [[STH]] by microscopy
@ -105,7 +105,9 @@
- Genomic resistance
- Genomic resistance
- Sample [[size]]: around 20k
- Sample [[size]]: around 20k
- Target population: School based
- Target population: School based
- Epidemiologic conditions on the sites: T
- Epidemiologic conditions on the sites: T. trichiura ongoing transmission areas
- Countries: [[Ghana]] and [[Kenya]]
- Proposed acceptability and feasiblity study
- Nuestros objetivos:
- Nuestros objetivos:
- Overall goal: Support the achievement of the [[WHO]] 2030 NTD Roadmap for [[STH]] and beyond
- Overall goal: Support the achievement of the [[WHO]] 2030 NTD Roadmap for [[STH]] and beyond
- Project purpose: Advance and accelerate an innovative pharmacological tool to support the elimination goals against [[STH]] species, especially those poorly responsive to current treatment regimens
- Project purpose: Advance and accelerate an innovative pharmacological tool to support the elimination goals against [[STH]] species, especially those poorly responsive to current treatment regimens
Borja Robert
11 months ago